NEW YORK (GenomeWeb) – Purigen Biosystems said today that it has raised $18.2 million in a Series A financing round, and plans to use the funds to further develop and commercialize its technology for automated preparation of genomic and genetic testing samples.

The round was led by 5AM Ventures and Roche Venture Fund, the company said, with participation from existing investors the Stanford-Startx Fund and Western Investments Capital.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.